Cleared Traditional

K870573 - T4 NO SPIN(TM) COATED TUBE RADIOIMMUNOA...

K870573 is the FDA 510(k) clearance for T4 NO SPIN(TM) COATED TUBE RADIOIMMUNOA... by Cambridge Medical Technology. It is a Class 2 Chemistry device (product code CDX) cleared through the Traditional 510(k) pathway after a 71-day FDA review.

K870573 · Cambridge Medical Technology · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1987
Decision
71d
Days
Class 2
Risk

K870573 is an FDA 510(k) clearance for the T4 NO SPIN(TM) COATED TUBE RADIOIMMUNOASSAY KIT. Classified as Radioimmunoassay, Total Thyroxine (product code CDX), Class II - Special Controls.

Submitted by Cambridge Medical Technology (Billerica, US). The FDA issued a Cleared decision on April 22, 1987 after a review of 71 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1700 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Cambridge Medical Technology devices

Submission Details

510(k) Number K870573 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 10, 1987
Decision Date April 22, 1987
Days to Decision 71 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
17d faster than avg
Panel avg: 88d · This submission: 71d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CDX Radioimmunoassay, Total Thyroxine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CDX Radioimmunoassay, Total Thyroxine

All 69
Devices cleared under the same product code (CDX) and FDA review panel - the closest regulatory comparables to K870573.
DELFIA(TM) THYROXINE (T4) KIT
K871303 · Lkb Instruments, Inc. · Jun 1987
MICROMEDIC NEONATAL T4 KIT
K871008 · Micromedic Systems · May 1987
CIBA CORNING MAGIC(R) LITE T4 IMMUNOASSAY
K870965 · Ciba Corning Diagnostics Corp. · May 1987
IQ T4 IMMUNOASSAY
K864560 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Dec 1986
MMS T4 RIA KIT
K861320 · Micromedic Systems · Apr 1986
STRAT TOTAL THYROXINE FLUOROMET ENZYME IMMUNOASSAY
K860421 · American Dade · Feb 1986